Search for: "BARTLETT v. STATE" Results 301 - 320 of 531
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Jul 2013, 5:00 am by Bexis
  The subject is preemption – specifically the the United States Supreme Court’s recent ruling in Mutual Pharmaceutical Company, Inc. v. [read post]
5 Jul 2013, 5:00 am by Bexis
Nev. 2011) (FDA compliance “relevant and admissible” but not “a bar to recovery”); Bartlett v. [read post]
3 Jul 2013, 6:42 am by Dan Stein
Bartlett, and American Express v. [read post]
2 Jul 2013, 7:32 am by Sarah Erickson-Muschko
Bartlett, holding that state-law design-defect claims which turn on the adequacy of a drug’s warnings are pre-empted by federal law. [read post]
1 Jul 2013, 10:16 am by Ronald Mann
Bartlett, and the message is that the Justices saw this case as essentially a replay of last year’s decision in PLIVA, Inc. v. [read post]
27 Jun 2013, 4:30 am by Steve McConnell
  Our tasty tater tot of a case for today’s consumption is Lederman v. [read post]
24 Jun 2013, 8:30 pm by constitutional lawblogger
Bartlett that the Federal Food, Drug, and Cosmetic Act, or FDCA, preempted a state-law design-defect claim against a generic drug manufacturer. [read post]
24 Jun 2013, 5:25 pm by Cicely Wilson
State-law design-defect claims based on the adequacy of a drug’s warnings are preempted by federal law under a 2011 Supreme Court decision, PLIVA, Inc. v. [read post]
24 Jun 2013, 11:30 am by Joe Consumer
Yet by the majority’s lights, the very act of creating that requirement in order to “safeguard the consumer,”  United  States v. [read post]
20 Jun 2013, 5:00 am by Bexis
While we’re waiting for the Supreme Court to issue its preemption ruling in the Bartlett case (possibly as early as 10:00 a.m. today), we thought we’d examine the Court’s recent preemption decisions in non-drug/medical device cases, Hillman v. [read post]